For information about Africhol's programs and activities, please contact:
Latest News, Outbreak Notifications:
Follow Africhol on Twitter
Haiti’s Cholera Epidemic Could Have Been Prevented With Low-cost Approaches, Study Finds
Yale School of Public Health (26 Jan 2016)
...New research by scientists at Yale School of Public Health, in partnership with colleagues at the Yale Law School, has found that simple and inexpensive interventions—which the United Nations has yet to implement—would be effective in preventing future outbreaks of the bacterial infection.
Cholera: the fight against the emergence of new strains
Discov Her (13 Jan 2016)
DiscovHER Dr Caroline Midonet, 2015 L'Oréal-UNESCO For Women in Science Fellow and Doctoral Researcher in the Institut de Biologie Intégrative de la Cellule (I2BC), at the Université Paris Sud.
WHO approves third cholera vaccine producer
Reuters (8 Jan 2016)
A third producer of oral cholera vaccine has been approved that is expected to provide 3 million doses in 2016, the World Health Organization said on Friday, doubling the world's stockpile against a disease that can kill within hours.
U.S. FDA Accepts BLA for PaxVax’s Single-Dose Oral Cholera Vaccine Vaxchora
BusinessWire (16 Dec 2015)
PaxVax Inc., a fully integrated specialty vaccine company committed to developing and commercializing innovative vaccines against infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the Biologics License Application (BLA) for its affiliate PaxVax Bermuda Ltd.’s single-dose oral cholera vaccine Vaxchora™.